SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to its announced all-stock merger with TAE Technologies, a fusion power company, in a transaction valued at over $6 billion. This strategic pivot to fusion energy, with plans for utility-scale plants by 2026, has sparked intense debate among investors. The community is sharply divided between those excited by the potential for powering AI and skeptics who view the move as highly speculative, questioning a social media company's foray into advanced energy.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending after reporting a significant earnings beat and providing exceptionally strong guidance, largely driven by booming demand for its High-Bandwidth Memory (HBM) which is reportedly sold out through 2026. This performance is widely seen by the community as a powerful validation of the AI supercycle, restoring enthusiasm to the semiconductor sector and leading to numerous analyst upgrades despite broader market caution.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is heavily trending following a cooler-than-expected inflation report, igniting hopes for potential future rate cuts and a robust year-end rally. Community sentiment is largely optimistic, anticipating new highs and a 'Santa rally,' although a skeptical contingent questions the data's validity. Strong Micron earnings are also bolstering positive sentiment, providing a potential boost to the broader tech sector amidst the ongoing market debate.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF is a central focus as market participants digest inflation data, with community sentiment divided between anticipating a "Santa rally" and bracing for a "sell the news" reaction. While some view recent economic signals and strong tech earnings as catalysts for continued upside, others express skepticism about the data's authenticity and the broader implications of central bank policies.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following news of a new development loan facility with Macquarie Group, specifically designed to fund pre-lease development for multiple AI data center campuses. The community views this non-dilutive financing as strong institutional validation for APLD's strategy in the burgeoning AI infrastructure sector, intensifying discussions around future growth and potential short squeezes.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is experiencing notable volatility, driven by a California court ruling challenging its 'Full Self-Driving' marketing claims and the broader market's reaction to economic data. The community remains sharply divided, with bulls anticipating a swift rebound towards new highs based on Elon Musk's long-term vision, while bears highlight regulatory hurdles and valuation concerns. This intense divergence in sentiment continues to fuel active discussion surrounding the company's technology and market trajectory.

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.

Processa Pharmaceuticals Inc

Processa Pharmaceuticals is trending following positive Phase 2 trial data for its breast cancer treatment, NGC-Cap, demonstrating improved efficacy with manageable side effects. This news has generated significant buzz, with many anticipating further upward movement due to the stock's small float and high short interest, while others caution about potential dilution and post-catalyst profit-taking.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands (TLRY) is actively trending as the cannabis sector anticipates a potential executive order to reclassify marijuana to Schedule III, a move widely expected to alleviate federal tax burdens and open doors for institutional investment. The community is buzzing with speculation about the timing of this significant policy shift and its transformative impact, with many debating if current market movements reflect the news or if further substantial gains are expected for leading sector players like Tilray.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

The AdvisorShares Pure US Cannabis ETF (MSOS) is trending on strong anticipation of a federal executive order to reclassify marijuana to Schedule III. The community is eagerly discussing the profound impact this reform would have on eliminating the burdensome 280E tax and unlocking significant institutional investment for US cannabis operators. Many expect a historic shift for the sector, driving conversations about potential major gains, though some anticipate short-term volatility.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently a focal point for investors, driven by a series of recent analyst downgrades citing concerns over branded checkout growth and execution challenges. This has intensified community debate, with many expressing frustration and suspicion that these downgrades are designed to allow institutions to accumulate shares at what they perceive as undervalued levels. The market is also digesting PayPal's strategic application to establish its own bank, a move some view as a potential long-term catalyst to fortify its financial ecosystem and enhance its valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fady Ibraham Malik Sells 2,200 Shares of Cytokinetics (NASDAQ:CYTK) Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Fady Ibraham Malik sold 2,200 shares of the company's stock in a transaction that occurred on Tuesday, December 16th. The shares were...

Sanders Morris Harris LLC Takes $1.18 Million Position in Cytokinetics, Incorporated $CYTK

Sanders Morris Harris LLC acquired a new position in Cytokinetics, Incorporated (NASDAQ:CYTK - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC...

Mirador Capital Partners LP Acquires 53,020 Shares of Cytokinetics, Incorporated $CYTK

Mirador Capital Partners LP increased its holdings in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Free Report) by 36.7% during the third quarter, according to its most recent Form 13F filing...

Cytokinetics (NASDAQ:CYTK) EVP Sells $134,728.00 in Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Fady Ibraham Malik sold 2,200 shares of Cytokinetics stock in a transaction that occurred on Tuesday, December 16th. The stock was sold...

Frazier Life Sciences Management L.P. Invests $18.33 Million in Cytokinetics, Incorporated $CYTK

Frazier Life Sciences Management L.P. acquired a new stake in Cytokinetics, Incorporated (NASDAQ:CYTK - Free Report) in the second quarter, according to its most recent disclosure with the Securities...

Needham & Company LLC Reaffirms "Buy" Rating for Cytokinetics (NASDAQ:CYTK)

Needham & Company LLC reiterated a "buy" rating and issued a $72.00 price objective on shares of Cytokinetics in a research report on Friday...

HighVista Strategies LLC Has $2.27 Million Stock Holdings in Cytokinetics, Incorporated $CYTK

HighVista Strategies LLC lifted its holdings in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Free Report) by 53.4% during the 2nd quarter, according to the company in its most recent filing...

Cytokinetics (NASDAQ:CYTK) EVP Andrew Callos Sells 1,042 Shares

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 1,042 shares of the stock in a transaction on Monday, December 8th. The stock was sold at an average price of $65.96...

Andrew Callos Sells 1,042 Shares of Cytokinetics (NASDAQ:CYTK) Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 1,042 shares of the stock in a transaction on Monday, December 8th. The shares were sold at an average price of...

Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares

Key PointsAdded 458,295 shares of Cytokinetics, a $25,187,893 net position change...

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

CYTK
Cytokinetics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CYTK News

CYTKCytokinetics Inc